Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-05-27
2000-11-21
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514254, 544368, A61K 31495, C07D41714
Patent
active
061503665
ABSTRACT:
Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 .mu.m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.
REFERENCES:
patent: 4831031 (1989-05-01), Lowe, III et al.
patent: 4883795 (1989-11-01), Lowe, III et al.
patent: 5206366 (1993-04-01), Bowles et al.
patent: 5264446 (1993-11-01), Hegasy et al.
patent: 5312925 (1994-05-01), Allen et al.
patent: 5338846 (1994-08-01), Busch et al.
patent: 5359068 (1994-10-01), Urban
patent: 5935960 (1999-08-01), Walinsky et al.
Arenson Daniel R.
Busch Frank Robert
Hausberger Angela G.
Rasadi Bijan
Benson Gregg C.
Jones James T.
Pfizer Inc.
Richardson Peter C.
Rose Shep K.
LandOfFree
Ziprasidone formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ziprasidone formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ziprasidone formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257434